bromfenac has been researched along with Acute Liver Injury, Drug-Induced in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Lee, WM | 1 |
Goldkind, L; Laine, L | 1 |
Temple, R | 1 |
Senior, JR | 1 |
Arana, A; Castellsague, J; Perez-Gutthann, S; Sanchez-Matienzo, D | 1 |
Alkhatib, O; Ferrentino, N; Lidofsky, SD; Moses, PL; Schroeder, B; Suppan, T | 1 |
Kaplowitz, N | 1 |
Appelman, HD; Benner, KG; Fontana, RJ; Gunartanam, NT; Lee, WM; McCashland, TM; Rabkin, JM; Wisecarver, JL | 1 |
3 review(s) available for bromfenac and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Drug-induced hepatotoxicity.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Hypoglycemic Agents; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Pharmaceutical Preparations; Pharmacology; Thiazoles; Thiazolidinediones; Troglitazone | 2003 |
A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience.
Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Archives; Benzophenones; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Humans; Liver; Phenylacetates; Propionates; Randomized Controlled Trials as Topic; United States; United States Food and Drug Administration | 2006 |
14 other study(ies) available for bromfenac and Acute Liver Injury, Drug-Induced
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hy's law: predicting serious hepatotoxicity.
Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2006 |
How can 'Hy's law' help the clinician?
Topics: Adverse Drug Reaction Reporting Systems; Alanine Transaminase; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Azetidines; Benzophenones; Benzylamines; Bilirubin; Biomarkers; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Drug Approval; Humans; Hypoglycemic Agents; Liver; Predictive Value of Tests; Randomized Controlled Trials as Topic; Risk Assessment; Thiazolidinediones; Troglitazone; United States; United States Food and Drug Administration | 2006 |
Hepatic disorders in patients treated with COX-2 selective inhibitors or nonselective NSAIDs: a case/noncase analysis of spontaneous reports.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Celecoxib; Chemical and Drug Induced Liver Injury; Cyclooxygenase 2 Inhibitors; Humans; Lactones; Odds Ratio; Pyrazoles; Safety; Sulfonamides; Sulfones; Sulindac | 2006 |
New warnings issued for bromfenac, astemizole.
Topics: Analgesics; Anti-Allergic Agents; Astemizole; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Drug Interactions; Drug Labeling; Humans; United States | 1998 |
Severe hepatotoxicity associated with bromfenac sodium.
Topics: Adult; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Failure | 1999 |
Avoiding hepatic injury from drugs.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Chromans; Humans; Hypoglycemic Agents; Liver Diseases; Thiazoles; Thiazolidinediones; Troglitazone | 1999 |
Acute liver failure associated with prolonged use of bromfenac leading to liver transplantation. The Acute Liver Failure Study Group.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Chemical and Drug Induced Liver Injury; Female; Humans; Liver; Liver Failure, Acute; Liver Transplantation; Middle Aged; Musculoskeletal Diseases; Time Factors | 1999 |